PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
Պահպանված է:
CHAKRABARTI, A., ET AL., PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY. DRUG AND ALCOHOL DEPENDENCE, Vol. 107, no. 2-3 (2010), p. 253-256.
Ref.
166786
Տեղադրություն:
SIIS R.854 Archivo
Palabras clave:
Adolescentes, Alcohol, Buprenorfina, Cannabis, Cocaína, Dosis, Drogodependencias, Edad, Evolución, Fármacos, Género, Juventud, Nicotina, Opiáceos, Raza, Tratamiento médico, EE.UU.
Adolescentes, Alcohol, Buprenorfina, Cannabis, Cocaína, Dosis, Drogodependencias, Edad, Evolución, Fármacos, Género, Juventud, Nicotina, Opiáceos, Raza, Tratamiento médico, EE.UU.
Նմանատիպ նյութեր: PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- A COMPARISON OF FOUR BUPRENORPHINE DOSING REGIMENS USING OPEN-DOSING PROCEDURES: IS TWICE-WEEKLY DOSING POSSIBLE?
- BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE: THE RELATIVE EFFICACY OF DAILY, TWICE AND THRICE WEEKLY DOSING
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
- THRICE WEEKLY SUPERVISED DOSING WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET IS PREFERRED TO DAILY SUPERVISED DOSING BY OPIOID-DEPENDET HUMANS
- DOSE EFFECTS AND PREDICTORS OF OUTCOME IN A RANDOMIZED TRIAL OF TRANSDERMAL NICOTINE PATCHES IN GENERAL PRACTICE